Locoregional relapse and distant metastases in conservatively managed triple negative early-stage breast cancer. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D. J Clin Oncol 2006 Dec 20;24(36):5652-7. Epub
Milgrom, S and Higgins SA. Management of cellulitis in patients with breast cancer. J Support Oncol. 7(5): 174-6, 2009
Clinical Utility of the Modified Segmental Boost Technique for Treatment of the Pelvis and Inguinal Nodes.
Moran MS, Castrucci WA, Ahmad M, Song H, Lund MW, Mani S, Chamberlain D, Higgins SA.
Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1026-36.
Brain metastases in epithelial ovarian and primary peritoneal carcinoma.
Ratner ES, Toy E, O'Malley DM, McAlpine J, Rutherford TJ, Azodi M, Higgins SA, Schwartz PE.
Int J Gynecol Cancer. 2009 Jul19(5):856-9.
Park HS, Ratner ES, Lucarelli L, Polizzi, S, Higgins SA, Damast S. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma. Brachytherapy. 2015 Jul-Aug; 14(4): 464-70. Epub 2015 Apr 14.
Golden DW, Braunstein S, Jiminez RB, Mohindra P, Spektor A, Ye JC; Radiation Onoclogy Education Collaborative Study Group Members. Multi-Institutional Implementation and Evaluation of a Curriculum for the Medical Student Clerkship in Radiation Oncology. J Am Coll Radiol. 13(2):203-9, 2016. J Am Coll Radiol. 13(2):203-9, 2016.
Ye JC, Mohindra P, Spektor A, Krishnan MS, Chmura SJ, Howard AR, Viswanathan AN, MacDonald SM, Tahaker NG, Das P, Mancini BR, Higgins SA, Braunstein S, Haas-Kogan D, Bradley KA, Hung AY, Thomas CR Jr, Kharofa J, Wheatley M, Currey A, Parashar B, Du K, Jiminiz RB, Golden DW. Medical Student Perspectives on a Multi-Institutional Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. Int J Radiat Oncol Bio Phys. 92(2): 217-9, 2015. Int J Radiat Oncol Bio Phys. 92(2): 217-9, 2015.
Damast S, Higgins SA, Ratner E, DeLeon MD, Mani S, Silasi DA, Azodi M, Santin A, Rutherford T, Schwartz PE. High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma. J Contemp Brachytherapy 2015 Feb; 7(1): 35-40. Epub 2015 Jan 26. J Contemp Brachytherapy. Feb; 7(1): 35-40, 2015 Epub 2015 Jan 26.
Khan AJ, Milgrom SA, Barnard N, Higgins SA, Moran M, Shahzad H, Kim S, Goyal S, Al-Faraj F, Kirstein L, Kearney T, Haffty BG. Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated with Locoregional Recurrence in a Case-Control Study of Women with 0-3 Positive Lymph Nodes After Mastectomy. 26. Khan AJ, Milgrom SA, Barnard N, Higgins SA, Moran M, Shahzad H, Kim S, Goyal S, Al-Faraj F, Kirstein L, Kearney T, Haffty BG. Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated with Locoregional Recurrence in a Case-Control Study of Women with 0-3 Positive Lymph Nodes After Mastectomy. Ann Surg Oncol 2014 Feb 22. [Epub ahead of print].
Evans SB, Panigrahi B, Northrup V, Patterson J, Baldwin DE, Higgins SA, Moran MS. Analysis of coronary artery dosimetry in the 3D era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):e55-60. Epub 2012 Jul 24. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):e55-60. Epub 2012 Jul 24.
Bai HX, Motwani SB, Higgins SA, Haffty BG, Wilson LD, Lannin DR, Evans SB, Moran MS. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? Int J Clin Oncol,19(3):460-6, 2014.
Lentz R, Ng R, Higgins S, Fusi S, Matthew M, Kwei S. Radiation therapy and expander-implant breast reconstruction: an analysis of timing and comparison of complications. Ann Plastic Surg, 71(3):269-73, 2013.
Rockwell SR, Grove TA, Liu Y, Cheng YC, Higgins SA, Booth CJ. Preclinical Studies of the Chinese Herbal Medicine Formulation PHY906 (KD018) As a Potential Adjunct to Radiation Therapy. Int J Radiat Biol, 89 (1) 16-25, 2013.
New treatments for many conditions are tested in clinical trials, which ultimately bring
lifesaving new drugs and devices to the patients who need them most.
By participating in a clinical trial, you may get access to the most advanced treatments
for your condition, and help determine their benefits for future patients.